Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Phase III Study of PI-88 in Post-resection Hepatocellular Carcinoma (PATHWAY)

This study has been terminated.
(Commercial decision to discontinue the study)
Information provided by:
Progen Pharmaceuticals Identifier:
First received: December 4, 2007
Last updated: June 13, 2011
Last verified: June 2011
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: July 2008
  Primary Completion Date: July 2008 (Final data collection date for primary outcome measure)